February 9, 2018 / 2:14 PM / 8 months ago

BRIEF-Salix Provides Update On FDA Submission For Plenvu

Feb 9 (Reuters) - Valeant Pharmaceuticals International Inc :

* SALIX PROVIDES UPDATE ON FDA SUBMISSION FOR PLENVU

* SALIX PHARMACEUTICALS- PDUFA ACTION DATE HAS BEEN EXTENDED TO ALLOW FDA MORE TIME TO REVIEW ADDITIONAL DATA THAT WAS RECENTLY PROVIDED AT ITS REQUEST

* SALIX PHARMACEUTICALS - FDA EXTENDED PDUFA ACTION DATE FOR REVIEW OF NDA FOR PLENVU (NER1006) BY THREE MONTHS TO MAY 13 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below